• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[甲状旁腺激素基因治疗甲状旁腺功能减退症的pcDNA3.1载体:一项实验研究]

[pcDNA3.1 parathyroid hormone gene therapy of hypoparathyroidism: an experimental study].

作者信息

Zhang Weihui, Song Chun, Wen Jimin, Song Chunfang

机构信息

Department of General Surgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2002 Aug 25;82(16):1133-5.

PMID:12425828
Abstract

OBJECTIVE

To investigate the effect of pcDNA3.1 parathyroid hormone (PTH) gene therapy for hypoparathyroidism and the best dosage.

METHODS

The parathyroid glands of 40 rabbits were resected so as to establish an animal model of hypoparathyroidism. The rabbits were randomly divided into 5 groups of 8 animals. Different doses of pcDNA3.1.PTH (50 micro g/kg, 150 micro g/kg, and 250 micro g/kg) containing human PTH gene, normal saline, and the vacant vector pcDNA3.1 were injected into the muscle of different groups of rabbits: Before parathyroidectomy and 1, 2, 3, 5, 7, 10, 15, 30, and 60 days after the operation blood was drawn to detect the concentrations of calcium and PTH.

RESULTS

The serum calcium and PTH began to increase one day after the injection of pcDNA3.1.PTH, and reached the peak concentrations at the seventh day. The levels lasted for two months. Seven days after the serum calcium and PTH were 2.83 +/- 0.02 mmol/L and 11.303 +/- 0.025 pg/ml respectively in 150 micro g/kg group and were 2.81 +/- 0.07 mmol/L and 12.001 +/- 0.008 pg/ml respectively in 250 micro g/kg group.

CONCLUSION

Human PTH gene therapy is effective in treating HPT with the most effective dose of 150 micro g/kg and 250 micro g/kg.

摘要

目的

探讨pcDNA3.1甲状旁腺激素(PTH)基因治疗甲状旁腺功能减退症的效果及最佳剂量。

方法

切除40只家兔的甲状旁腺以建立甲状旁腺功能减退症动物模型。将家兔随机分为5组,每组8只。分别向不同组家兔肌肉注射不同剂量含人PTH基因的pcDNA3.1.PTH(50μg/kg、150μg/kg和250μg/kg)、生理盐水及空载体pcDNA3.1:在甲状旁腺切除术前及术后1、2、3、5、7、10、15、30和60天采血检测血钙和PTH浓度。

结果

注射pcDNA3.1.PTH后1天血清钙和PTH开始升高,第7天达到峰值浓度。该水平持续两个月。第7天时,150μg/kg组血清钙和PTH分别为2.83±0.02mmol/L和11.303±0.025pg/ml,250μg/kg组分别为2.81±0.07mmol/L和12.001±0.008pg/ml。

结论

人PTH基因治疗甲状旁腺功能减退症有效,最有效剂量为150μg/kg和250μg/kg。

相似文献

1
[pcDNA3.1 parathyroid hormone gene therapy of hypoparathyroidism: an experimental study].[甲状旁腺激素基因治疗甲状旁腺功能减退症的pcDNA3.1载体:一项实验研究]
Zhonghua Yi Xue Za Zhi. 2002 Aug 25;82(16):1133-5.
2
[pcDPG parathyroid hormone gene therapy of hypoparathyroidism: an experimental study].[甲状旁腺激素基因治疗甲状旁腺功能减退症:一项实验研究]
Zhonghua Yi Xue Za Zhi. 2006 Jan 24;86(4):260-5.
3
[pCKM-mPTH recombinant plasmid therapy for hypoparathyroidism: an in vivo experimental research with rats].[甲状旁腺功能减退症的pCKM - mPTH重组质粒疗法:大鼠体内实验研究]
Zhonghua Yi Xue Za Zhi. 2004 Dec 17;84(24):2107-9.
4
Optimising gene therapy of hypoparathyroidism with hematopoietic stem cells.优化造血干细胞治疗甲状旁腺功能减退症的基因疗法。
Chin Med J (Engl). 2005 Feb 5;118(3):204-9.
5
[pCKM-mPTH recombinant plasmid therapy for hypoparathyroidism by polycationic liposome-mediated transfection].[聚阳离子脂质体介导转染的pCKM-mPTH重组质粒疗法治疗甲状旁腺功能减退症]
Zhonghua Yi Xue Za Zhi. 2006 Mar 28;86(12):837-40.
6
Oral gene therapy for hypoparathyroidism: a rat model.甲状旁腺功能减退症的口服基因治疗:大鼠模型。
Hum Gene Ther. 2009 Nov;20(11):1344-50. doi: 10.1089/hum.2009.015.
7
[Allotransplantation of cultured fetal parathyroid gland cells in treating patients with hypoparathyroidism].培养的胎儿甲状旁腺细胞同种异体移植治疗甲状旁腺功能减退症患者
Zhonghua Wai Ke Za Zhi. 2000 Sep;38(9):690-2.
8
[Experimental study of dually targeting gene therapy system for pituitary adenomas].垂体腺瘤双靶点基因治疗系统的实验研究
Zhonghua Yi Xue Za Zhi. 2005 Jan 26;85(4):262-6.
9
Cica clamp evaluation of parathyroid responsiveness in chronic hypoparathyroidism: a sequential citrate and calcium clamp study.慢性甲状旁腺功能减退症中甲状旁腺反应性的西卡钳评估:一项序贯柠檬酸盐和钙钳研究
Miner Electrolyte Metab. 1994;20(3):135-40.
10
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.